Cargando…
Identification of a novel binding inhibitor that blocks the interaction between hSCARB2 and VP1 of enterovirus 71
Enterovirus 71 (EV-A71) infection causes severe hand-foot-and-mouth disease that leads to cardiopulmonary complications and death in young children under 5 years of age. Although there are available vaccines for EV-A71 C(4), however, there are no efficient drugs for severe cases. Thus, there is an u...
Autores principales: | Tang, Qi, Xu, Zhichao, Zhang, Fan, Cai, Yang, Chen, Yinuo, Lu, Baojing, Zhou, Hai-bing, Lan, Ke, Wu, Shuwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120312/ https://www.ncbi.nlm.nih.gov/pubmed/37193133 http://dx.doi.org/10.1016/j.cellin.2022.100016 |
Ejemplares similares
-
A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis
por: Chen, Yanli, et al.
Publicado: (2021) -
A practical method for evaluating the in vivo efficacy of EVA-71 vaccine using a hSCARB2 knock-in mouse model
por: Wu, Yong, et al.
Publicado: (2021) -
Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71
por: Lin, Yi-Wen, et al.
Publicado: (2013) -
Recombinant Human SCARB2 Expressed in Escherichia coli and its Potential in Enterovirus 71 Blockage
por: Vo-Nguyen, Hai-Vy, et al.
Publicado: (2021) -
Long-term psychiatric outcomes in youth with enterovirus A71 central nervous system involvement
por: Lin, Hsiang-Yuan, et al.
Publicado: (2022)